- The new vaccine is “similar to the existing mRNA vaccine but uses a smaller protein,” Kennedy says in a post on X
- The FDA will monitor and collect data throughout the trial for every adverse outcome: Kennedy
To contact the reporter on this story:
To contact the editors responsible for this story:
Airielle Lowe
© 2025 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.